Opoka, Robert O.
Namazzi, Ruth
Datta, Dibyadyuti
Bangirana, Paul
Conroy, Andrea L.
Goings, Michael J.
Mellencamp, Kagan A.
John, Chandy C.
Funding for this research was provided by:
National Institutes of Neurological Disorders and Stroke (R01 NS055349, R01 NS055349, R01 NS055349, R01 NS055349, R01 NS055349, R01 NS055349, R01 NS055349, R01 NS055349)
Fogarty International Center (D43 D43TW010928, D43 D43TW010928, D43 D43TW010928, D43 D43TW010928, D43 D43TW010928, D43 D43TW010928, D43 D43TW010928, D43 D43TW010928)
Article History
Received: 17 September 2024
Accepted: 26 November 2024
First Online: 4 December 2024
Declarations
:
: Initial verbal consent from the parents or legal guardians of study participants was obtained for children fulfilling inclusion criteria, since most participants were critically ill and required emergency stabilization. Written informed consent was obtained once the participant was clinically stabilized. Ethical approval was granted by the Institutional Review Boards at Makerere University School of Medicine, the University of Minnesota, Indiana University, and regulatory approval granted by the Uganda National Council for Science and Technology. The study was conducted in accordance with the ethical standards of the Helsinki Declaration.
: Not applicable.
: The authors declare no competing interests.